"This technology will allow us to get the right drug, to the right person, at the right time," says Maynes, highlighting the precision of their robotic system in drug delivery.
The robotic technology developed enables testing of therapeutics for arrhythmogenic cardiomyopathy, overcoming traditional drug screening limitations in beating heart tissue.
Unlike cancer cells, heart conditions present a challenge due to the dynamic movement of heart cells, complicating traditional drug screening methods.
The tiny robot incorporates a z-shaped micropipette and a 3D imaging system, offering a solution to accurately inject fluorescent molecules into beating heart cells.
Collection
[
|
...
]